Dr Vincent Giampapa

Vincent Giampapa, MD, develops cellular regeneration and DNA repair technologies through his work with Vectracell's peptide delivery platform. His research focuses on addressing age-related functional decline, particularly in muscle and cognitive performance. The Edison Award recipient and Nobel Prize nominee specializes in translating biomedical innovations into therapeutic applications. Based in New Jersey, Dr. Giampapa advances regenerative medicine through three core areas: cellular aging mechanisms, DNA modification techniques, and tissue restoration protocols. His scientific contributions span laboratory research, clinical applications, and educational initiatives in longevity science. The physician-scientist maintains active involvement in regenerative hospitality ventures while conducting ongoing studies in healthspan optimization. Dr. Giampapa's research examines the biological processes of aging at the cellular level, investigating potential interventions for age-related conditions. His work integrates findings from molecular biology, regenerative medicine, and therapeutic delivery systems. The resulting protocols aim to address functional deterioration through targeted cellular repair mechanisms.